Comparison of modified MAZE with minimally invasive monopolar ablation and traditional bipolar radiofrequency ablation in the treatment of atrial fibrillation

Atrial fibrillation (AF) is the most common atrial arrhythmia, with an activation frequency of 350–600 beats/min. The typical characters of AF are absence of clear P waves, presence of f waves, irregularly irregular ventricular rhythm and QRS complex < 0.12 s. Based on the Global Burden of Diease Database, the global morbidity rate of AF is 0.5% [1]. Thomas Wilke et al. showed a morbidity rate of atrial fibrillation of 2.132% through a study of 8.3 million patients in Germany [2]. The average age of these patients was 73.1 years old. A study in China showed that the overall morbidity rate of atrial fibrillation was 0.77% [3], and 0.65% after standardization according to the 2010 census results [4]. The risk of stroke and congestive heart failure in patients with atrial fibrillation is respectively 3 times and 5 times higher than that of the general population, and the patients‘quality of life is affected to some extent [5].

The etiology and pathophysiological mechanisms of atrial fibrillation are still unclear. The current mainstream hypothesis includes multiple wavelet re-entry hypothesis [6] and focal activation theory [7, 8]. The most common surgery of atrial fibrillation is the Cox-MAZE procedure, first reported by Cox et al. in 1989 [9‐12]. The classic maze procedure is highly surgical technique dependent, with long operation time and high complication rates. Therefore a series of modified maze techniques, such as cryoablation [13], radiofrequency ablation, microwave ablation [14], etc., have been developed. The most currently used surgery is the modified type III MAZE.

Radiofrequency ablation (RF) mainly includes monopolar ablation and bipolar ablation. Martin-Suarez et al. compared bipolar radiofrequency ablation maze, monopolar radiofrequency ablation and interventional therapy [15]. They confirmed that the success rate of bipolar radiofrequency ablation maze is higher than that of monopolar and percutaneous intervention. Geidel et al. did a long-term follow-up of patients undergoing radiofrequency ablation, finding although the atrial fibrillation ablation rate in bipolar and monopolar RF modified maze was not significantly different, the operation time for bipolar radiofrequency ablation was significantly shorter than that of monopolar radiofrequency ablation, thus bipolar ablation is strongly recommended [16]. Besides the improvements in energy technology, the application of minimally invasive techniques has also improved MAZE procedure. The Wolf mini-MAZE is the most famous minimally invasive modified MAZE procedure. It is operated with a bipolar radiofrequency ablation forceps, assisted by thoracoscope through small incisions on both sides of the chest wall, with a continuous atrial fibrillation ablation rate of 85%. Although long-term follow-up results are unsatisfactory, the technique is less invasive and it does not need extracorporeal circulation [17]. Different from Wolf mini-MAZE, this study aimed to test the atrial fibrillation ablation rate and postoperative quality of life after the modified minimally invasive MAZE with monopolar radiofrequency ablation innovatively.

The preoperative baseline characteristics of the patients included in the study are shown in Table 1. Twenty-four women and 18 men were included in the mi-MAZE group, and the os-MAZE group included 46 women and 19 men (P = 0.148). The average age of mi-MAZE group was 56.8 ± 11.29 years and that of the os-MAZE group was 59.5 ± 10.04 years. Heart function was assessed using NYHA classification, and the overall difference between two groups was not significant. Of the 42 patients in the mi-MAZE group, 16 (38.1%) had hypertension, 25 (59.5%) had palpitations, 5 (11.9%) had type 2 diabetes mellitus, and 8 (19.0%) had pulmonary hypertension; One of the 65 patients in the os-MAZE group (1.5%) had COPD, 21 (32.3%) had hypertension, 28 (43.1%) had palpitations, and 14 (21.5%) had type 2 diabetes, 22 (33.8%) with pulmonary hypertension; there was no significant difference between the two groups. Preoperative cardiac ultrasonography measured LAD, LVDd, which were not significantly different. However, average LVEF was significantly lower and LVDs was significantly higher in the mi-MAZE group than that in the os-MAZE group (P = 0.001, Table 1). There was no significant difference of Euroscore between the two groups.

During the operation, the mi-MAZE group had longer extracorporeal circulation time (Table 2), which may be related to thoracoscopic inconvenience. There was no significant difference in operative time between the two groups, indicating that the bipolar ablation group spent more time on the chest opening and closing than the monopolar ablation group. No adverse events occurred in both groups, such as myocardial infarction, acute renal insufficiency or death.

42 (100%) patients in the mi-MAZE group and 65 (100%) patients in the os-MAZE group recovered sinus rhythm when the operation finished. The two groups also had similar ICU stays and hospital stays (Table 3). During hospitalization, 7 of 42 patients in the mi-MAZE group (16.7%) had recurrent atrial fibrillation, 4 (9.5%) developed atrioventricular block, 8 (19.0%) developed pulmonary infection, and 3 (7.1%) had a second operation including one with thoracotomy for hemotasis and another for a pacemaker implantation. Nineteen of the 65 patients in the os-MAZE group (29.2%) had recurrent AF and 6 (9.2%) had pulmonary infection. Methionine, digoxin, L-carnitine, metoprolol, isosorbide mononitrate, diuretics and other drugs were routinely used during hospitalization (Table 3). All patients were discharged uneventfully.

After surgery, we followed up 40 patients (2 patients had wrong telephone numbers) in the mi-MAZE group and 62 patients (3 patients withdraw) in the os-MAZE group. It was found that 31 patients (77.5%) in the mi-MAZE group were sinus rhythm 3 months after operation. However, 1 of the 31 patients became atrial flutter 6 months after operation. After treatment in hospital, he eventually recovered (Table 4). In the os-MAZE group, 44 (71.0%) recovered sinus rhythm 3 months after operation. After that, 2 more patients became atrial flutter (Table 4). Echocardiographic data showed no significant differences in LAD, LVDs, LVDd, and LVEF between the two groups 12 months after operation (Table 4 and Fig. 1c). We followed up these patients on the phone or in person and scored them on the SF-36 scale. The results 3 months after operation were found to be 120.2 ± 8.10 and 110.6 ± 6.58 (P < 0.001, Table 4). And the 12 months results were 123.5 ± 6.09 vs 119.3 ± 6.25 (mi-MAZE group vs os-MAZE group, P = 0.028, Table 4). The higher the score, the better the quality of life after surgery.

The rate of normal sinus rhythm in the mi-MAZE group before operation was significantly different from that of the end of operation (Fig. 2). And the rates were similar 3 months, 6 months and 12 months after operation (Fig. 2).

The MAZE procedure was first reported by Cox et al. in 1989 [9‐12]. The basic technique was to use a cut-suture technique to separate the myocardium with multiple lines to make it to accept the activation of sinus node, while the atrial fibrillation wave could not be expanded. All of type I-III maze procedures use traditional cut-suture techniques to ablate atrial fibrillation. The type III maze is improved on the basis of type I maze, which reduces the risk of dysfunctional insufficiency and node conduction caused by type I and type II maze. To date, type III maze still has the highest atrial fibrillation ablation rate and is therefore the gold standard for atrial fibrillation ablation.

This study reached the following conclusions by comparing the baseline characteristics of the mi-MAZE group and the os-MAZE group before, during, and after surgery, and the results of 3 months’ follow-up. First, there was no significant difference in the rates of sinus rhythm between the mi-MAZE group and the os-MAZE group (77.5% vs 71.0%, P = 0.465, Table 4) 3 months after surgery, which means there was no significant difference in the surgical outcome between the two procedures. This result is consistent with the findings of the study by Geidel et al. [16] As we all know, the Wolf mini-MAZE is the most famous minimally invasive modified MAZE [17]. It is operated with a thoracoscope-assisted bipolar radiofrequency ablation clamp through small incisions on both sides of the chest wall. The postoperative atrial fibrillation ablation rate is 85%. Although long-term follow-up results are less than ideal, the technique has the advantage of less invasive and no need for extracorporeal circulation. Our minimally invasive monopolar radiofrequency ablation modified MAZE is different from the Wolf mini-MAZE. The surgical procedure used a monopolar ablation pen assisted by thoracoscopy, with extracorporeal circulation still required (because of mitral valve surgery). Compared with the study by Wolf et al., our minimally invasive monopolar radiofrequency ablation modified MAZE procedure resulted in a postoperative sustained atrial fibrillation ablation rate of 77.5% 12 months after operation.

In addition, this study showed that echocardiographic data was not significantly different between the two groups 12 months after the surgery. In addition, we used the SF-36 scale to assess the quality of life of patients and found that the quality of life score was significantly higher in the mi-MAZE group 12 months after operation (P = 0.028, Table 4). This indicates that the mi-MAZE group has greater quality of life, which includes the incision is easy to heal and the recovery is better. Although the extracorporeal circulation time of the monopolar ablation group was significantly higher than that of the bipolar ablation group, there was no significant difference in the overall operation time between the two groups, nor in the proportion of adverse events during hospitalization. Therefore, we recommend a minimally invasive monopolar radiofrequency ablation modified MAZE operation for the patients who had a history of atrial fibrillation less than 2 years with a left atrial diameter < 60 mm combined with mitral valve diseases.

There are still some limitations in our research, such as the small sample size, which makes the research results less confirmative. The mi-MAZE procedure has been started since 2014 in the Department of Cardiothoracic Surgery, First Affiliated Hospital of Zhejiang University. We have already collected as many patients as we could. Secondly, limited to one center, regional differences cannot be considered. Thirdly, since the latest mi-MAZE was in May 31, 2018, the longest follow-up period for this patient is only 12 months, which is still long enough for us to focus on primary and intermediate effectiveness of the two surgeries. Baseline balance was achieved as far as possible in patients before receiving surgeries, but there were still some significant differences. For example, preoperative LVEF was higher in the mi-MAZE group. Later, prospective studies should be carried on to explore the effects of minimally invasive monopolar radiofrequency ablation modified MAZE surgery.

This study is intended to evaluate the effectiveness of monopolar radiofrequency ablation in atrial fibrillation and the safety and superiority of minially invasive procedure. We mainly focus on primary and intermediate effectiveness of mi-MAZE and os-MAZE, and also on the differences of postoperative complications and quality of life between minimally invasive procedure and traditional sternotomy.

There was no significant difference in atrial fibrillation ablation rates (sinus rhythm recovery rates) between the minimally invasive MAZE with monopolar radiofrequency ablation group and the open surgery MAZE with bipolar radiofrequency ablation group. The atrial fibrillation ablation rate of the mi-MAZE group achieved 77.5%. For the 3, 6, and 12 month postoperative SF-36 score, the mi-MAZE group was always significantly higher than the os-MAZE group. If a patient had a history of atrial fibrillation less than 2 years and with a left atrial diameter < 60 mm combined with mitral valve diseases, the minimally invasive monopolar radiofrequency ablation modified MAZE operation would be recommended.